These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 10873231)

  • 1. The role of quantitative neurological examination in clinical neurotoxicology.
    Bleecker ML
    Neurol Clin; 2000 Aug; 18(3):563-78. PubMed ID: 10873231
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peripheral neurotoxic disorders.
    Bromberg MB
    Neurol Clin; 2000 Aug; 18(3):681-94. PubMed ID: 10873238
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Agreement between clinical examination and quantitative tests of neurologic function among 384 subjects.
    Steenland K; Dick R; Fine L
    Am J Ind Med; 2001 Apr; 39(4):361-8. PubMed ID: 11323785
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Standardization of quantitative tests for preclinical detection of neuromotor dysfunctions in pediatric neurotoxicology.
    Després C; Richer F; Roberge MC; Lamoureux D; Beuter A
    Neurotoxicology; 2005 Jun; 26(3):385-95. PubMed ID: 15935210
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidemiological case definitions of peripheral neuropathy: experience from two neurotoxicity studies.
    Gerr F; Letz R
    Neurotoxicology; 2000 Oct; 21(5):761-8. PubMed ID: 11130280
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decision rules for assessment of chronic solvent-induced encephalopathy: Results in 2370 patients.
    Verberk MM; van der Hoek JA; van Valen E; Wekking EM; van Hout MS; Hageman G; van der Laan G; van Dijk FJ
    Neurotoxicology; 2012 Aug; 33(4):742-52. PubMed ID: 22722000
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A brief review of cognitive assessment in neurotoxicology.
    Han DY; Hoelzle JB; Dennis BC; Hoffmann M
    Neurol Clin; 2011 Aug; 29(3):581-90. PubMed ID: 21803211
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detecting chronic solvent encephalopathy in occupations at risk.
    Furu H; Sainio M; Hyvärinen HK; Akila R; Bäck B; Uuksulainen S; Kaukiainen A
    Neurotoxicology; 2012 Aug; 33(4):734-41. PubMed ID: 22560996
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suboptimal performance on neuropsychological tests in patients with suspected chronic toxic encephalopathy.
    van Hout MS; Schmand B; Wekking EM; Hageman G; Deelman BG
    Neurotoxicology; 2003 Aug; 24(4-5):547-51. PubMed ID: 12900068
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Measuring behavior.
    Boll TJ
    Neurol Clin; 2000 Aug; 18(3):579-600. PubMed ID: 10873232
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prediction of neuropsychological performance by neurological signs in schizophrenia.
    Arango C; Bartko JJ; Gold JM; Buchanan RW
    Am J Psychiatry; 1999 Sep; 156(9):1349-57. PubMed ID: 10484944
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Controversies in neurotoxicology: current status.
    Albers JW; Berent S
    Neurol Clin; 2000 Aug; 18(3):741-64. PubMed ID: 10873241
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation of medical and neurosurgical events with neuropsychological status in children at diagnosis of astrocytoma: utilization of a neurological severity score.
    Ater JL; Moore BD; Francis DJ; Castillo R; Slopis J; Copeland DR
    J Child Neurol; 1996 Nov; 11(6):462-9. PubMed ID: 9120225
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A screening programme on chronic solvent-induced encephalopathy among Dutch painters.
    Spee T; van Valen E; van Duivenbooden C; van der Laan G
    Neurotoxicology; 2012 Aug; 33(4):727-33. PubMed ID: 22664100
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurologic evaluation of workers previously diagnosed with solvent-induced toxic encephalopathy.
    Albers JW; Wald JJ; Garabrant DH; Trask CL; Berent S
    J Occup Environ Med; 2000 Apr; 42(4):410-23. PubMed ID: 10774510
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pitfalls in clinical assessment of neurotoxic diseases: negative effects of repeated diagnostic evaluation, illustrated by a clinical case.
    van Hout M; Hageman G; van Valen E
    Neurotoxicology; 2014 Dec; 45():247-52. PubMed ID: 24406376
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Psychological, neuropsychological, and electrocortical effects of mixed mold exposure.
    Crago BR; Gray MR; Nelson LA; Davis M; Arnold L; Thrasher JD
    Arch Environ Health; 2003 Aug; 58(8):452-63. PubMed ID: 15259424
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A meta-analysis of the sensitivity of various neuropsychological tests used to detect chemotherapy-induced cognitive impairment in patients with breast cancer.
    Jansen CE; Miaskowski CA; Dodd MJ; Dowling GA
    Oncol Nurs Forum; 2007 Sep; 34(5):997-1005. PubMed ID: 17878128
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurological and Neurophysiological Findings in Workers with Chronic 2,3,7,8-Tetrachlorodibenzo-p-Dioxin Intoxication 50 Years After Exposure.
    Pelclova D; Urban P; Fenclova Z; Vlckova S; Ridzon P; Kupka K; Meckova Z; Bezdicek O; Navratil T; Rosmus J; Zakharov S
    Basic Clin Pharmacol Toxicol; 2018 Feb; 122(2):271-277. PubMed ID: 28862800
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Strategies and tools for preventing neurotoxicity: to test, to predict and how to do it.
    Llorens J; Li AA; Ceccatelli S; Suñol C
    Neurotoxicology; 2012 Aug; 33(4):796-804. PubMed ID: 22342764
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.